Back to search

Article

Celecoxib added to risperidone for depressive symptoms in first-episode and drug naïve schizophrenia: Pharmacogenetic impact of BDNF gene polymorphisms

2022-06-01

Abstract excerpt

<title>Abstract</title> <p>Although depressive symptoms are common in patients with schizophrenia (SCZ), depression is not successfully treated in most SCZ patients. SCZ Patients with comorbid depression may have activated inflammatory responses, and celecoxib, a COX2 inhibitor, can dampen inflammation and improve treatment of depression. BDNF may be associated with the treatment response to antidepressants and h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
831a69fe-7c63-5657-906c-8e650c2de415
DOI
10.21203/rs.3.rs-1700453/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Celecoxib added to risperidone for depressive symptoms in first-episode and drug naïve schizophrenia: Pharmacogenetic impact of BDNF gene polymorphismsDOI 10.21203/rs.3.rs-1700453/v1
Select a neighboring publication to make it the new centre.